ID: ALA4129196

Max Phase: Preclinical

Molecular Formula: C21H26N4O3S

Molecular Weight: 414.53

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N=C(N)c1ccc(NC(=O)[C@H](NS(=O)(=O)c2ccccc2)C2CCCCC2)cc1

Standard InChI:  InChI=1S/C21H26N4O3S/c22-20(23)16-11-13-17(14-12-16)24-21(26)19(15-7-3-1-4-8-15)25-29(27,28)18-9-5-2-6-10-18/h2,5-6,9-15,19,25H,1,3-4,7-8H2,(H3,22,23)(H,24,26)/t19-/m1/s1

Standard InChI Key:  NQBRJBOXVWMMJV-LJQANCHMSA-N

Associated Targets(Human)

Serine protease hepsin 242 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Urokinase-type plasminogen activator 2016 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 414.53Molecular Weight (Monoisotopic): 414.1726AlogP: 2.84#Rotatable Bonds: 7
Polar Surface Area: 125.14Molecular Species: BASEHBA: 4HBD: 4
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.13CX Basic pKa: 11.44CX LogP: 2.56CX LogD: 0.65
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.41Np Likeness Score: -0.98

References

1. Pant SM, Mukonoweshuro A, Desai B, Ramjee MK, Selway CN, Tarver GJ, Wright AG, Birchall K, Chapman TM, Tervonen TA, Klefström J..  (2018)  Design, Synthesis, and Testing of Potent, Selective Hepsin Inhibitors via Application of an Automated Closed-Loop Optimization Platform.,  61  (10): [PMID:29701962] [10.1021/acs.jmedchem.7b01698]

Source